DEFINITIVE PROXY STATEMENT

Company

REGENERON PHARMACEUTICALS, INC.

Filed

April 28, 2011

Period of Report

June 10, 2011

Accession Number

0001206774-11-001031

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →